New heart pump trial offers hope for End-Stage heart failure patients

NCT ID NCT05353816

Ongoing Disease control Sponsor: Shenzhen Core Medical Technology CO.,LTD. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial is testing a new mechanical heart pump called the Corheart 6 in 50 people with end-stage heart failure. The pump is implanted to help the heart circulate blood. Researchers are checking if the device works safely and effectively at 3 months and 2 years after implantation, focusing on survival without major stroke or device problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Corheart 6 Left Ventricular Assist Device (a mechanical heart pump)
What this could lead to: If successful, this device could offer a reliable, long-term option to keep people with severe heart failure alive and active while they wait for a transplant or as a permanent solution.
What could go wrong: This is an early-stage trial with only 50 participants, so results may not apply to everyone. Risks include stroke, device failure, or infection, and the device requires ongoing medical management.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

advanced heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

END-STAGE HEART FAILURE

Contacts and locations

Locations

Fujian Medical University Union Hospital

Fuzhou, Fujian, China
Fuwai Central China Cardiovascular Hospital

Zhengzhou, Hunan, China
Fuwai Hospital, Chinese Academy of Medical Sciences(CAMS)

Beijing, Beijing Municipality, China
Guangdong Provincial People's Hospital

Guangzhou, Guangdong, China
Nanjing First Hospital

Nanjing, Jiangsu, China
People's Hospital of Xinjiang Uygur Autonomous Region

Xinjiang, Xinjiang, China
The First Affiliated Hospital of Soochow University

Suzhou, Jiangsu, China
The Second XIANGYA Hospital Of Central South University

Changsha, Hunan, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China
Xijing Hospital of Air Force Medical University

Xi’an, Shanxi, China
Zhongshan Hospital, Fudan University

Shanghai, Shanghai Municipality, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.